Plasma endostatin correlates with hypoxia and mortality in COVID-19-associated acute respiratory failure

Conclusion: Our results suggest that plasma endostatin is an early biomarker for disease severity in COVID-19.PMID:34668393 | DOI:10.2217/bmm-2021-0111

Source: Future Medicine: Biomarkers in Medicine - October 20, 2021 Category: Internal Medicine Authors: Sana Asif Thoralph Ruge Anders Larsson Sara B ülow Anderberg Miklos Lipcsey Robert Fritiof Michael Hultstr öm Source Type: research